A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder

Phase 3 Completed 330 enrolled Forest Laboratories

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the long-term safety and tolerability of vilazodone for the treatment of MDD in pediatric outpatients (7-17 years).

Timeline

Start: 2015-05-02
Primary completion: 2018-07-23
Completion: 2018-07-23

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vilazodone	Small molecule	—	Oral

A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder

Summary

Timeline

Drugs

Indications